S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case

Cellebrite DI (CLBT) Earnings Date, Estimates & Call Transcripts

$11.71
+0.01 (+0.09%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

CLBT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLBT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellebrite DI Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.32 EPS
Next Year EPS Consensus Estimate: $0.41 EPS

CLBT Earnings Date and Information

Cellebrite DI has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

Cellebrite DI Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
11/14/2023Q3 2023$0.01$0.09+$0.08$0.15$82.13 million$84.20 million    
8/8/2023Q2 2023$0.03$0.05+$0.02$0.27$72.52 million$76.70 million    
5/10/2023Q1 2023$0.03$0.03-$0.27$69.42 million$71.23 million
2/15/2023Q4 2022$0.04$0.06+$0.02$0.08$74.78 million$74.02 million
11/17/2022Q3 2022$0.03($0.01)($0.04)($0.15)$73.00 million$71.68 million
5/12/2022Q1 2022$0.04$0.01($0.03)($0.25)$61.90 million$62.39 million
2/16/2022Q4 2021$0.02$0.03+$0.01($0.19)$64.00 million$67.91 million
11/10/2021Q3 2021$0.01$0.07+$0.06$0.09$58.80 million$65.89 million












Cellebrite DI Earnings - Frequently Asked Questions

When is Cellebrite DI's earnings date?

Cellebrite DI has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on CLBT's earnings history.

How much revenue does Cellebrite DI generate each year?

Cellebrite DI (NASDAQ:CLBT) has a recorded annual revenue of $325.11 million.

How much profit does Cellebrite DI generate each year?

Cellebrite DI (NASDAQ:CLBT) has a recorded net income of -$81.10 million. CLBT has generated -$0.43 earnings per share over the last four quarters.

What is Cellebrite DI's price-to-earnings ratio?

Cellebrite DI (NASDAQ:CLBT) has a forward price-to-earnings ratio of 36.59. The price/earnings-to-growth ratio is 2.06.

What is Cellebrite DI's EPS forecast for next year?

Cellebrite DI's earnings are expected to grow from $0.32 per share to $0.41 per share in the next year, which is a 28.13% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:CLBT) was last updated on 2/25/2024 by MarketBeat.com Staff